clarithromycin has been researched along with Acute Liver Injury, Drug-Induced in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (33.33) | 18.2507 |
2000's | 3 (16.67) | 29.6817 |
2010's | 9 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jeon, K; Kim, BJ; Kim, CK; Koh, WJ; Kook, YH; Kwon, OJ; Lee, NY; Lee, SH; Park, YK | 1 |
Bambara, LM; Biasi, D; Caramaschi, P; Mahamid, H | 1 |
Cağlayan Yeğen, B; Can, G; Deniz, M; Duman, DG; Ercan, F; Kumral, ZN | 1 |
D'Ambrosi, M; Giannattasio, A; Iorio, R; Volpicelli, M | 1 |
Brown, BA; Girard, W; Griffith, DE; Wallace, RJ | 1 |
Chau, CH; Lee, J; Leung, CW; Yew, WW | 1 |
Marneff, E; Saint-Marc, T; Touraine, JL | 1 |
Bachmeyer, C; Biour, M; Bouraya, D; Cadranel, JF; Mougeot-Martin, M; Pourvillain, S; Pras, V | 1 |
Bernardo, A; Correia, J; Santos, J; Silvestre, F; Sousa, C | 1 |
Baylor, P; Williams, K | 1 |
Borrás, J; Gutiérrez, F; Jimeno, A; Martín-Hidalgo, A; Masiá, M; Matarredona, J; Navarro, A | 1 |
2 review(s) available for clarithromycin and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clarithromycin-induced hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Clarithromycin; Humans | 1995 |
1 trial(s) available for clarithromycin and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
[Mycobacterium avium intracellulare infections. Treatment with a clarithromycin-clofazimine combination. 18 cases].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Chemical and Drug Induced Liver Injury; Clarithromycin; Clofazimine; Drug Therapy, Combination; Humans; Male; Middle Aged; Mycobacterium avium-intracellulare Infection | 1993 |
15 other study(ies) available for clarithromycin and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Chemical and Drug Induced Liver Injury; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Liver; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Neutropenia; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Thrombocytopenia; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Liver impairment after concomitant administration of bosentan and clarithromycin in systemic sclerosis.
Topics: Aged; Anti-Bacterial Agents; Antihypertensive Agents; Bosentan; Chemical and Drug Induced Liver Injury; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fingers; Humans; Hypertension, Pulmonary; Liver Function Tests; Middle Aged; Scleroderma, Systemic; Skin Ulcer; Sulfonamides | 2010 |
Saccharomyces boulardii ameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in rats.
Topics: Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antioxidants; Chemical and Drug Induced Liver Injury; Clarithromycin; Diarrhea; Gastrointestinal Transit; Glutathione; Ileum; Inflammation; Intestinal Diseases; Lipid Peroxidation; Liver; Male; Malondialdehyde; Methotrexate; Neutrophil Infiltration; Oxidative Stress; Peroxidase; Probiotics; Rats; Rats, Sprague-Dawley; Saccharomyces | 2013 |
Steroid therapy for a case of severe drug-induced cholestasis.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Cholestasis; Clarithromycin; Drug Therapy, Combination; Female; Humans; Liver; Liver Function Tests; Respiratory Tract Infections; Sulfonamides | 2006 |
Cholestatic hepatitis in a patient who received clarithromycin therapy for a Mycobacterium chelonae lung infection.
Topics: Chemical and Drug Induced Liver Injury; Clarithromycin; Humans; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Respiratory Tract Infections | 1994 |
[Acute symptomatic cytolytic hepatitis probably related to clarithromycin].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Clarithromycin; Female; Humans | 1996 |
[Cholestatic hepatitis probably induced by clarithromycin].
Topics: Aged; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Clarithromycin; Humans; Male | 1997 |
Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy.
Topics: Aged; Amylases; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Clarithromycin; Humans; Male; Nephritis, Interstitial; Thrombocytopenia | 1999 |
Fulminant hepatitis and fatal toxic epidermal necrolysis (Lyell disease) coincident with clarithromycin administration in an alcoholic patient receiving disulfiram therapy.
Topics: Alcohol Deterrents; Alcoholism; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Clarithromycin; Cytochrome P-450 Enzyme Inhibitors; Disulfiram; Drug Interactions; Enzyme Inhibitors; Fatal Outcome; Humans; Male; Middle Aged; Stevens-Johnson Syndrome | 2002 |